B. E. Demiryurek Et Al. , "Effects of onabotulinumtoxinA treatment on efficacy, depression, anxiety, and disability in Turkish patients with chronic migraine," NEUROLOGICAL SCIENCES , vol.37, no.11, pp.1779-1784, 2016
Demiryurek, B. E. Et Al. 2016. Effects of onabotulinumtoxinA treatment on efficacy, depression, anxiety, and disability in Turkish patients with chronic migraine. NEUROLOGICAL SCIENCES , vol.37, no.11 , 1779-1784.
Demiryurek, B. E., Ertem, D. H., Tekin, A., Ceylan, M., Aras, Y. G., & Gungen, B. D., (2016). Effects of onabotulinumtoxinA treatment on efficacy, depression, anxiety, and disability in Turkish patients with chronic migraine. NEUROLOGICAL SCIENCES , vol.37, no.11, 1779-1784.
Demiryurek, Bekir Et Al. "Effects of onabotulinumtoxinA treatment on efficacy, depression, anxiety, and disability in Turkish patients with chronic migraine," NEUROLOGICAL SCIENCES , vol.37, no.11, 1779-1784, 2016
Demiryurek, Bekir E. Et Al. "Effects of onabotulinumtoxinA treatment on efficacy, depression, anxiety, and disability in Turkish patients with chronic migraine." NEUROLOGICAL SCIENCES , vol.37, no.11, pp.1779-1784, 2016
Demiryurek, B. E. Et Al. (2016) . "Effects of onabotulinumtoxinA treatment on efficacy, depression, anxiety, and disability in Turkish patients with chronic migraine." NEUROLOGICAL SCIENCES , vol.37, no.11, pp.1779-1784.
@article{article, author={Bekir Enes Demiryurek Et Al. }, title={Effects of onabotulinumtoxinA treatment on efficacy, depression, anxiety, and disability in Turkish patients with chronic migraine}, journal={NEUROLOGICAL SCIENCES}, year=2016, pages={1779-1784} }